Succinylcholine: A Drug to Avoid in Bariatric Surgery
- 204 Downloads
Succinylcholine is a paralytic agent regularly utilized in anesthesia. There are numerous adverse effects of succinylcholine ranging from mild to fatal; one such effect is succinylcholine myalgia. We report the case of a 34-year-old woman who received succinylcholine while undergoing laparoscopic Roux-en-Y gastric bypass and later developed succinylcholine myalgia leading to a prolonged hospital stay and subsequent pneumonia. In the presence of suitable alternative paralytic agents, succinylcholine should be avoided in patients undergoing bariatric surgery. The use of a designated anesthesia team familiar with bariatric operations can help maximize peri-operative management and minimize complications.
KeywordsObstructive Sleep Apnea Gastric Bypass Succinylcholine Rocuronium Motor Neuron Disease
- 12.Kazanjian PE. Anesthesia complications. In: Mulholland MW, Doherty GA, editors. Complications in surgery. Baltimore: Lippincott Williams & Wilkins; 2005. p. 78–80.Google Scholar
- 16.Morgan GE, Mikhail MS, Murray MJ. Clinical Anesthesiology. Fourth Edition. McGraw Hill. 2005:213–215.Google Scholar
- 19.Schering-Plough, Schering-Plough News Release. U.S. FDA Issues Action Letter for Sugammadex. http://www.schering-plough.com/schering_plough/news/release.jsp?releaseID=1182475. Accessed August 26, 2008.
- 20.Pühringer FK, Rex C, Sielenkämper AW, et al. Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial. Anesthesiology 2008;109:188–97.CrossRefGoogle Scholar